Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00160303 · ClinicalTrials.gov registry record · Phase 3
Efficacy Study of Prolotherapy vs Corticosteroid for Tennis Elbow
A Phase 3 study, sponsored by Spaulding Rehabilitation Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 56
- Enrollment target
NCT00160303 is a Phase 3 study that has completed, run by Spaulding Rehabilitation Hospital. The registered enrollment target is 56 participants.
The verdict
NCT00160303, a Phase 3 study, has completed, sponsored by Spaulding Rehabilitation Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 56 participants
- Enrollment target
Study Summary
The purpose of the research is to study the effects of two different injection therapies for the treatment of lateral epicondylitis (tennis elbow). Specifically, we will look at which therapy provides better short and long-term relief of pain, which treatment allows better function and less disability, and which treatment gives back better strength in the affected hand. Each subject will receive only one of the two treatments. Although both of these treatments are usually very well tolerated, it is important to make this comparison because it is believed that one of these therapies may have better long term effectiveness, with a lower cost, and smaller number of potential side effects.
Interventions
- DRUG Prolotherapy
- DRUG Local Corticosteroid Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2005-01 |
| Est. Completion | 2006-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00160303
The ClinicalTrials.gov registry entry for NCT00160303 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Spaulding Rehabilitation Hospital, which has 101 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Prolotherapy is the first listed.
NCT00160303 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00160303 about?
NCT00160303 is a clinical study titled "Efficacy Study of Prolotherapy vs Corticosteroid for Tennis Elbow". The purpose of the research is to study the effects of two different injection therapies for the treatment of lateral epicondylitis (tennis elbow). Specifically, we will look at which therapy provides better short and long-term relief of pain, which treatment allows better function and less disabili...
What is the current status of trial NCT00160303?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 56 participants. The study started on 2005-01. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00160303?
The interventions under investigation include: Prolotherapy (DRUG), Local Corticosteroid Therapy (DRUG).
Who is sponsoring clinical trial NCT00160303?
This trial is sponsored by Spaulding Rehabilitation Hospital, which has 101 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.